Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read General business news Ester Industries (NSE: ESTER) rides polymer momentum despite Q2 FY26 net loss Ester’s Q2 FY26 results show specialty polymers gaining ground amid film margin pressure. Find out how ELITe and global tie-ups could reshape its future. bySrinathNovember 17, 2025